Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Lippman, SM"'
Autor:
Sacco AG; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA. Electronic address: agsacco@health.ucsd.edu., Chen R; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA; Division of Biostatistics, Herbert Wertheim School of Public Health, University of California, San Diego, La Jolla, CA, USA., Worden FP; Rogel Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA., Wong DJL; Los Angeles Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA., Adkins D; Siteman Comprehensive Cancer Center, Washington University, St Louis, MO, USA., Swiecicki P; Rogel Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA., Chai-Ho W; Los Angeles Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA., Oppelt P; Siteman Comprehensive Cancer Center, Washington University, St Louis, MO, USA., Ghosh D; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA., Bykowski J; Department of Radiology, University of California, San Diego, La Jolla, CA, USA., Molinolo A; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA., Pittman E; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA., Estrada MV; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA., Gold K; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA., Daniels G; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA., Lippman SM; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA., Natsuhara A; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA., Messer K; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA; Division of Biostatistics, Herbert Wertheim School of Public Health, University of California, San Diego, La Jolla, CA, USA., Cohen EEW; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Jun; Vol. 22 (6), pp. 883-892. Date of Electronic Publication: 2021 May 11.
Prognostic implications of RAS alterations in diverse malignancies and impact of targeted therapies.
Autor:
Kato S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Okamura R; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Sicklick JK; Center for Personalized Cancer Therapy and Division of Surgical Oncology, Department of Surgery, UC San Diego Moores Cancer Center, La Jolla, California., Daniels GA; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Goodman A; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Weihe E; Department of Radiology, UC San Diego Moores Cancer Center, La Jolla, California., Lee S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Khalid N; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Collier R; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Mareboina M; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Riviere P; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Whitchurch TJ; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Fanta PT; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Lippman SM; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Kurzrock R; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California.
Publikováno v:
International journal of cancer [Int J Cancer] 2020 Jun 15; Vol. 146 (12), pp. 3450-3460. Date of Electronic Publication: 2020 Jan 29.
Autor:
Yamaguchi K; Moores Cancer Center, University of California San Diego, San Diego, CA, USA., Iglesias-Bartolomé R; Laboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA., Wang Z; Moores Cancer Center, University of California San Diego, San Diego, CA, USA., Callejas-Valera JL; Moores Cancer Center, University of California San Diego, San Diego, CA, USA., Amornphimoltham P; Moores Cancer Center, University of California San Diego, San Diego, CA, USA., Molinolo AA; Moores Cancer Center, University of California San Diego, San Diego, CA, USA., Cohen EE; Moores Cancer Center, University of California San Diego, San Diego, CA, USA., Califano JA; Moores Cancer Center, University of California San Diego, San Diego, CA, USA., Lippman SM; Moores Cancer Center, University of California San Diego, San Diego, CA, USA., Luo J; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute (CCR-NCI), National Institutes of Health, Bethesda, MD, USA., Gutkind JS; Moores Cancer Center, University of California San Diego, San Diego, CA, USA.; Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Publikováno v:
Oncotarget [Oncotarget] 2016 Mar 08; Vol. 7 (10), pp. 10696-709.
Autor:
Pu X; Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hildebrandt MA; Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lu C; Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Roth JA; Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stewart DJ; Division of Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, Ontario., Zhao Y; Department of Environmental Health, Harvard School of Public Health, Boston, MA., Heist RS; Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Ye Y; Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chang DW; Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Su L; Department of Environmental Health, Harvard School of Public Health, Boston, MA., Minna JD; Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Lippman SM; Rebecca and John Moores Cancer Center, The University of California San Diego, San Diego, CA., Spitz MR; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA., Christiani DC; Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Wu X; Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2014 Sep; Vol. 96 (3), pp. 360-369. Date of Electronic Publication: 2014 Apr 22.
Autor:
Wu X; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1340, Houston, TX 77030, USA. xwu@mdanderson.org, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MA, Roth JA, Minna JD, Gu J, Lin J, Buch SC, Nukui T, Ramirez Serrano JL, Taron M, Cassidy A, Lu C, Chang JY, Lippman SM, Hong WK, Spitz MR, Romkes M, Yang P
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2011 May 18; Vol. 103 (10), pp. 817-25. Date of Electronic Publication: 2011 Apr 11.
Autor:
Moinpour CM; Southwest Oncology Group Statistical Center, Seattle, WA 98105, USA. cmoinpou@fhcrc.org, Vaught NL, Goldman B, Redman MW, Philip PA, Millwood B, Lippman SM, Seay TE, Flynn PJ, O'Reilly EM, Rowland KM, Wong RP, Benedetti J, Blanke CD
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 Aug 01; Vol. 28 (22), pp. 3611-6. Date of Electronic Publication: 2010 Jul 06.
Autor:
William WN Jr; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA., Kies MS, Fossella FV, Liu DD, Gladish G, Tse WH, Lee JJ, Hong WK, Lippman SM, Kim ES
Publikováno v:
Cancer [Cancer] 2010 May 15; Vol. 116 (10), pp. 2401-8.
Autor:
William WN Jr; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Khuri FR, Fossella FV, Glisson BS, Zinner RG, Lee JJ, Herbst RS, Lippman SM, Kim ES
Publikováno v:
American journal of clinical oncology [Am J Clin Oncol] 2010 Apr; Vol. 33 (2), pp. 148-52.
Autor:
Kies MS; Departments of Thoracic/Head and Neck Medical Oncology, Head and Neck Surgery, Radiation Oncology, Biostatistics, Radiology, and Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. mkies@mdanderson.org, Holsinger FC, Lee JJ, William WN Jr, Glisson BS, Lin HY, Lewin JS, Ginsberg LE, Gillaspy KA, Massarelli E, Byers L, Lippman SM, Hong WK, El-Naggar AK, Garden AS, Papadimitrakopoulou V
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 Jan 01; Vol. 28 (1), pp. 8-14. Date of Electronic Publication: 2009 Nov 16.
Autor:
Zinner RG; Department of Thoracic/Head and Neck Medical Oncology, Unit 432, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. rzinner@mdanderson.org, Barrett BL, Popova E, Damien P, Volgin AY, Gelovani JG, Lotan R, Tran HT, Pisano C, Mills GB, Mao L, Hong WK, Lippman SM, Miller JH
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2009 Mar; Vol. 8 (3), pp. 521-32. Date of Electronic Publication: 2009 Mar 10.